Published in Diabet Med on May 01, 1984
Proteinuria: value as predictor of cardiovascular mortality in insulin dependent diabetes mellitus. Br Med J (Clin Res Ed) (1987) 2.88
Prevalence of microalbuminuria, arterial hypertension, retinopathy and neuropathy in patients with insulin dependent diabetes. Br Med J (Clin Res Ed) (1988) 2.84
Predictors of mortality in insulin dependent diabetes: 10 year observational follow up study. BMJ (1996) 2.00
Microalbuminuria as predictor of increased mortality in elderly people. BMJ (1990) 1.85
Microalbuminuria. BMJ (1992) 1.35
Microalbuminuria in non-insulin-dependent diabetes: its prevalence in Indian compared with Europid patients. Br Med J (Clin Res Ed) (1988) 1.29
Cohort study of predictive value of urinary albumin excretion for atherosclerotic vascular disease in patients with insulin dependent diabetes. BMJ (1996) 1.07
Amadori-modified glycated serum proteins and accelerated atherosclerosis in diabetes: pathogenic and therapeutic implications. J Lab Clin Med (2006) 0.93
Microalbuminuria in inflammatory bowel disease. Gut (1994) 0.93
Microalbuminuria in non-insulin-dependent (type 2) Nigerian diabetics: relation to glycaemic control, blood pressure and retinopathy. Postgrad Med J (1992) 0.92
Metabolic acidosis-induced insulin resistance and cardiovascular risk. Metab Syndr Relat Disord (2011) 0.91
Cardiovascular mortality in non-insulin-dependent diabetes mellitus. A controlled study among 683 diabetics and 683 age- and sex-matched normal subjects. Eur J Epidemiol (2000) 0.86
Incidence of microalbuminuria in tobacco chewers. Indian J Clin Biochem (2005) 0.84
The impact of hormonal contraceptives on blood pressure, urinary albumin excretion and glomerular filtration rate. Br J Clin Pharmacol (2007) 0.83
An interaction between the interleukin-6 -174G>C gene variant and urinary protein excretion influences plasma oxidative stress in subjects with type 2 diabetes. Cardiovasc Diabetol (2004) 0.83
Obesity, albuminuria and hypertension among Hong Kong Chinese with non-insulin-dependent diabetes mellitus (NIDDM). Postgrad Med J (1993) 0.82
Microalbuminuria in systemic sclerosis. Ann Rheum Dis (1992) 0.80
Diabetic nephropathy. Prevention and early referral. Can Fam Physician (2000) 0.79
Impact of microalbuminuria on incident coronary heart disease, cardiovascular and all-cause mortality: a meta-analysis of prospective studies. Int J Clin Exp Med (2015) 0.78
Danish general practitioners' estimation of urinary albumin concentration in the detection of proteinuria and microalbuminuria. Br J Gen Pract (1995) 0.77
Microproteinuria in patients with inflammatory bowel disease: is it associated with the disease activity or the treatment with 5-aminosalicylic acid? World J Gastroenterol (2006) 0.76
Microalbuminuria and coronary heart disease in non-diabetics. Postgrad Med J (1993) 0.75
Prevalence of microalbuminuria, lipoprotein (a) and coronary artery disease in the lipid clinic. J Clin Pathol (1996) 0.75
Impaired aerobic work capacity in insulin dependent diabetics with increased urinary albumin excretion. Br Med J (Clin Res Ed) (1988) 0.75
Predictive value of microalbuminuria in longstanding insulin dependent diabetes. BMJ (1993) 0.75
Dose Modification of Antidiabetic Agents in Patients with Type 2 Diabetes Mellitus and Heart Failure. Indian J Endocrinol Metab (2017) 0.75
Smoking and other risk factors for coronary heart-disease in British civil servants. Lancet (1976) 15.18
Cardiorespiratory disease and diabetes among middle-aged male Civil Servants. A study of screening and intervention. Lancet (1974) 10.02
Myocardial ischaemia, risk factors and death from coronary heart-disease. Lancet (1977) 6.97
Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet (1982) 6.93
Coronary-heart-disease risk and impaired glucose tolerance. The Whitehall study. Lancet (1980) 4.86
Prevention of diabetic renal disease with special reference to microalbuminuria. Lancet (1995) 4.06
High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic men. 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study. Diabetes Care (1998) 3.94
Hyperglycaemia and diabetes mellitus. Lancet (1976) 3.57
Weight and mortality in the Whitehall Study. Br Med J (Clin Res Ed) (1982) 3.35
Mortality from coronary heart disease and stroke in relation to degree of glycaemia: the Whitehall study. Br Med J (Clin Res Ed) (1983) 3.28
The British Diabetic Association Cohort Study, II: cause-specific mortality in patients with insulin-treated diabetes mellitus. Diabet Med (1999) 3.26
Community care service for diabetics in the Poole area. Br Med J (1976) 3.00
Effect of control of blood glucose on urinary excretion of albumin and beta2 microglobulin in insulin-dependent diabetes. N Engl J Med (1979) 2.87
Affinity chromatography of cereal alpha-amylase. Anal Biochem (1976) 2.83
The concomitants of raised blood sugar: studies in newly-detected hyperglycaemics: II. Urinary albumin excretion, blood pressure and their relation to blood sugar levels. Int J Epidemiol (2013) 2.70
The British Diabetic Association Cohort Study, I: all-cause mortality in patients with insulin-treated diabetes mellitus. Diabet Med (1999) 2.31
The Oxford Community Diabetes Study: evidence for an increase in the prevalence of known diabetes in Great Britain. Diabet Med (1988) 2.03
A cereal haemoglobin gene is expressed in seed and root tissues under anaerobic conditions. Plant Mol Biol (1994) 2.02
The prevalence of diabetes mellitus in a typical English community. J R Coll Physicians Lond (1985) 1.99
Oral glucose tolerance and related factors in a normal population sample. I. Blood sugar, plasma insulin, glyceride, and cholesterol measurements and the effects of age and sex. Br Med J (1969) 1.96
An endogenous alpha-amylase inhibitor in barley kernels. Plant Physiol (1983) 1.93
Continuous subcutaneous insulin infusion in the treatment of diabetes mellitus. Diabetes Care (1980) 1.92
Haemostatic variables associated with diabetes and its complications. Br Med J (1979) 1.90
Diurnal variation of oral glucose tolerance: a possible pointer to the evolution of diabetes mellitus. Br Med J (1969) 1.81
The ten-year follow-up of the Bedford survey (1962-1972): glucose tolerance and diabetes. Diabetologia (1982) 1.79
Proposed factor structure of the Geriatric Depression Scale. Int Psychogeriatr (1991) 1.76
The Bedford survey: ten year mortality rates in newly diagnosed diabetics, borderline diabetics and normoglycaemic controls and risk indices for coronary heart disease in borderline diabetics. Diabetologia (1982) 1.71
Worsening to diabetes in men with impaired glucose tolerance ("borderline diabetes"). Diabetologia (1979) 1.61
Diurnal variation in oral glucose tolerance: blood sugar and plasma insulin levels morning, afternoon, and evening. Br Med J (1972) 1.61
Mortality rates in diabetic patients from a community-based population compared to local age/sex matched controls. Diabet Med (1997) 1.60
Is screening and intervention for microalbuminuria worthwhile in patients with insulin dependent diabetes? BMJ (1993) 1.58
Expression, purification, and properties of recombinant barley (Hordeum sp.) hemoglobin. Optical spectra and reactions with gaseous ligands. J Biol Chem (1997) 1.56
Hemodynamic factors in the genesis of diabetic microangiopathy. Metabolism (1983) 1.56
Glomerular hyperfiltration as a risk factor for diabetic nephropathy: five-year report of a prospective study. Diabetologia (1991) 1.55
Restriction of dietary protein and progression of renal failure in diabetic nephropathy. Lancet (1989) 1.55
Increased glomerular permeability to albumin induced by exercise in diabetic subjects. Diabetologia (1978) 1.51
Hypomagnesaemia in IDDM patients with microalbuminuria and clinical proteinuria. Diabetologia (1994) 1.50
Diabetes mellitus: a new look at diagnostic criteria. Diabetologia (1979) 1.49
Prognostic significance of microalbuminuria in insulin-dependent diabetes mellitus: a twenty-three year follow-up study. Kidney Int (1992) 1.47
Safety of continuous subcutaneous insulin infusion: metabolic deterioration and glycaemic autoregulation after deliberate cessation of infusion. Diabetologia (1982) 1.46
Multicenter evaluation of the Micral-Test II test strip, an immunologic rapid test for the detection of microalbuminuria. Diabetes Care (1997) 1.45
Oral glucose-tolerance tests and the diagnosis of diabetes: results of a prospective study based on the Whitehall survey. Lancet (1979) 1.43
Serum leptin concentration in moderate and severe obesity: relationship with clinical, anthropometric and metabolic factors. Int J Obes Relat Metab Disord (1999) 1.39
A man with diabetes and unexplained renal failure. Lancet (1998) 1.39
Very mild senile dementia of the Alzheimer type. II. Psychometric test performance. Arch Neurol (1989) 1.37
Obesity and overweight in relation to organ-specific cancer mortality in London (UK): findings from the original Whitehall study. Int J Obes (Lond) (2005) 1.36
Changes in oral glucose tolerance during the menstrual cycle. Br Med J (1968) 1.36
Characterization of a gene family encoding abscisic acid- and environmental stress-inducible proteins of alfalfa. J Biol Chem (1992) 1.36
Further observations on the diurnal variation in oral glucose tolerance. Br Med J (1970) 1.35
Intestinal hormones and plasma-insulin. Lancet (1966) 1.35
Nutrient intake, adiposity, and diabetes. Br Med J (1979) 1.34
Type 2 (non-insulin-dependent) diabetes mellitus and coronary heart disease-chicken, egg or neither? Diabetologia (1984) 1.34
The role of circulating glucose and triglyceride concentrations and their interactions with other "risk factors" as determinants of arterial disease in nine diabetic population samples from the WHO multinational study. Diabetes Care (1983) 1.32
Long term correction of hyperglycaemia and progression of renal failure in insulin dependent diabetes. Br Med J (Clin Res Ed) (1983) 1.31
Seal lungs collapse during free diving: evidence from arterial nitrogen tensions. Science (1985) 1.30
Alternative pathway respiration and lipoxygenase activity in aged potato slice mitochondria. Plant Physiol (1982) 1.30
Obesity and overweight in relation to disease-specific mortality in men with and without existing coronary heart disease in London: the original Whitehall study. Heart (2005) 1.29
Microalbuminuria in diabetes: a population study of the prevalence and an assessment of three screening tests. Diabet Med (1988) 1.29
Microalbuminuria in non-insulin-dependent diabetes: its prevalence in Indian compared with Europid patients. Br Med J (Clin Res Ed) (1988) 1.29
Monitoring glomerular function in diabetic nephropathy. A prospective study. Am J Med (1983) 1.25
Hemoglobin concentrations and blood gas tensions of free-diving Weddell seals. J Appl Physiol (1985) (1986) 1.25
Glucose tolerance and blood pressure in two population samples: their relation to diabetes mellitus and hypertension. Int J Epidemiol (1978) 1.25
Human insulin produced by recombinant DNA technology: safety and hypoglycaemic potency in healthy men. Lancet (1980) 1.24
The effect of treatment of moderate hypergly- caemia on the incidence of arterial disease. Postgrad Med J (1968) 1.24
Altering hemoglobin levels changes energy status in maize cells under hypoxia. Proc Natl Acad Sci U S A (1998) 1.23
Leukotriene D4: a potent coronary artery vasoconstrictor associated with impaired ventricular contraction. Science (1982) 1.23
Adenosine triphosphatase of bean plastids: its properties and site of formation. Plant Physiol (1972) 1.23
Blood pressure, retinopathy and urinary albumin excretion in IDDM: the EURODIAB IDDM Complications Study. Diabetologia (1995) 1.22
Reflections on gestational diabetes mellitus. Lancet (1981) 1.22
Subclinical hypothyroidism in obese patients: relation to resting energy expenditure, serum leptin, body composition, and lipid profile. Obes Res (2001) 1.22
Glycaemia, arterial pressure and micro-albuminuria in type 1 (insulin-dependent) diabetes mellitus. Diabetologia (1984) 1.22
Genesis and evolution of diabetic nephropathy. J Clin Pathol (1981) 1.21
Elevated serum levels of macrophage-derived cytokines precede and accompany the onset of IDDM. Diabetologia (1996) 1.21
The variability of overnight urinary albumin excretion in insulin-dependent diabetic and normal subjects. Diabet Med (1987) 1.19
Screening for early diabetic nephropathy: which sample to detect microalbuminuria? Diabet Med (1985) 1.19
Induction of alpha-amylase inhibitor synthesis in barley embryos and young seedlings by abscisic Acid and dehydration stress. Plant Physiol (1989) 1.18
Evidence of an increasing prevalence of diagnosed diabetes mellitus in the Poole area from 1983 to 1996. Diabet Med (1998) 1.17
Inhibition of nitric oxide synthesis in forearm vasculature of insulin-dependent diabetic patients: blunted vasoconstriction in patients with microalbuminuria. Clin Sci (Lond) (1993) 1.16
Intestinal hormones and plasma insulin: an insulinotropic action of secretin. Br Med J (1967) 1.16
An optical practice based diabetic eye screening programme. Diabet Med (1995) 1.16
Oral glucose tolerance and related factors in a normal population sample. II. Interrelationship of glycerides, cholesterol, and other factors with the glucose and insulin response. Br Med J (1969) 1.15
The WHO multinational study of vascular disease in diabetes: 1. General description. Diabetes Care (1980) 1.14
Metabolic syndrome in obese Caucasian children: prevalence using WHO-derived criteria and association with nontraditional cardiovascular risk factors. Int J Obes (Lond) (2006) 1.13
Urinary excretion of albumin in normal man: the effect of water loading. Scand J Clin Lab Invest (1982) 1.13
A prospective study of mortality among middle-aged diabetic patients (the London Cohort of the WHO Multinational Study of Vascular Disease in Diabetics) I: Causes and death rates. Diabetologia (1990) 1.13
Plasma lipid and coagulation factor concentrations in insulin dependent diabetics with microalbuminuria. BMJ (1989) 1.13
Oxidation of sugars, other than glucose, by isolated mammalian islets of Langerhans. Metabolism (1968) 1.09